stockrowCumberland Pharmaceuticals Inc. (CPIX) vs InterCure Ltd. (INCR)
- Cumberland Pharmaceuticals Inc. CPIX 5.24 +4.59%
- InterCure Ltd. INCR 3.25 −1.52%
Cumberland Pharmaceuticals Inc. and InterCure Ltd. are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. is the larger, with a market value of $75.1M against $39.1M — 1.9× the size. Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 6.2×. InterCure Ltd. grew revenue faster over the last twelve months: 16.2% against −25.7%. InterCure Ltd. has the higher net margin (4.88% vs −34.9%) and the higher return on invested capital (0.00% vs −34.2%). Across the 18 metrics below, InterCure Ltd. leads on 12 and Cumberland Pharmaceuticals Inc. on 6.
Valuation
Profitability
| Metric | CPIX | INCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 110.49% | 32.74% | 53.51% |
| Operating margin | (23.20%) | 0.00% | 0.00% |
| Net margin | (34.92%) | 4.88% | (2.45%) |
| Free cash flow margin | 1.84% | 0.00% | 0.00% |
| Return on equity | (48.76%) | 0.00% | (0.80%) |
| Return on assets | (16.70%) | 0.00% | (1.67%) |
| Return on invested capital | (34.23%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack